Eton Pharmaceuticals, Inc. vs. Exela Pharma Sciences, LLC
Explore the PTAB proceeding PGR2020-00064 filed by Eton Pharmaceuticals, Inc. on 2020-05-19. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
PGR2020-00064
Filing Date
2020-05-19
Accorded Filing Date
2020-05-19
Institution Decision Date
2020-11-18
Last Modified Date
—
Proceeding Type
PGR
Termination Date
—
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Eton Pharmaceuticals, Inc.
Represented By
Gabric, Ralph et alPatent Owner / Respondent
Exela Pharma Sciences, LLC
Represented By
Whelan, Dorothy et alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34141 | Michael Connor | +1 704-444-1022 |
| 34610 | Guy Gosnell | +1 704-444-1000 |
| 35704 | George Taulbee | +1 704-444-1000 |
| 37505 | Joe Liebeschuetz | +1 650-838-2038 |
| 38114 | Jason Cooper | +1 404--88-1-7000 |
| 38337 | David Teske | +1 404-881-7000 |
| 42365 | Keith Broyles | +1 404-881-7000 |
| 44316 | Susan Sather | +1 650-838-2069 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 21 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 10,478,453 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,583,155 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,933,089 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,905,713 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,653,719 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,912,795 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,905,714 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,918,662 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,510,941 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,510,942 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,672,824 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,684,636 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,648,262 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,679,125 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,642,370 B1 | US Continuation / Sibling | View Official Patent → |
Nexus Pharmaceuticals LLC v. Exela Pharma Sciences, LLC
Eton Pharmaceuticals, Inc. v. Exela Pharma Sciences LLC
Eton Pharmaceuticals Inc. v. Exela Pharma Sciences, LLC
Exela Pharma Sciences, LLC v. Avadel Legacy Pharmaceuticals, LLC